AGENTA BIOTECHNOLOGIES, INC.

Basic Information

Innovation Depot
1500 1st Ave. N.
BIRMINGHAM, AL, 35203-

Company Profile

Biotechnology Research and Development

Additional Details

Field Value
DUNS: 192801814
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. DNA Pro-Drug Technology in Localized Wound Healing and Tissue Regeneration

    Amount: $157,069.00

    DESCRIPTION (provided by applicant): Advancement in wound management or tissue repair has been limited by the complexities, costs and limited efficacy of purified recombinant growth factors. Further, ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Nucleic acid delivery of growth factors and heparan sulfate proteoglycans for enh

    Amount: $156,792.00

    DESCRIPTION (provided by applicant): In chronic wounds, numerous factors contribute to the diminished healing. Wound healing constituents, including heparan sulfate proteoglycans and numerous growth f ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Molecular Heparan Sulfate Delivery in Guided Tissue Regeneration

    Amount: $1,087,460.00

    DESCRIPTION (provided by applicant): Barrier membranes are an important adjunct to regeneration therapy aimed at restoring the form and function of the mouth. Commercially available barrier membranes ...

    SBIR Phase II 2009 Department of Health and Human Services
  4. Molecular Heparan Sulfate Delivery in Guided Tissue Regeneration

    Amount: $94,058.00

    DESCRIPTION (provided by applicant): The role of proteoglycans and carbohydrate polymers such as heparan sulfate in biological processes are becoming better understood, but this new frontier has only ...

    SBIR Phase I 2007 Department of Health and Human Services
  5. Molecular Delivery of Heparan Sulfate in Wound Regeneration

    Amount: $421,260.00

    DESCRIPTION (provided by applicant): The role of proteoglycans and carbohydrate polymers such as heparan sulfate in biological processes are becoming better understood, but this new frontier has only ...

    SBIR Phase II 2007 Department of Health and Human Services
  6. Molecular Probes for Platelet Heparanase-Digested

    Amount: $121,980.00

    DESCRIPTION (provided by applicant): The project proposed by Agenta Biotechnologies, Inc. will produce diagnostic molecular tools to identify where destructive changes in skin, kidney, heart, eyes, bo ...

    SBIR Phase I 2006 Department of Health and Human Services
  7. Molecular Heparan Sulfate Delivery in Wound Regeneration

    Amount: $114,597.00

    DESCRIPTION (provided by applicant): Tissue engineering, grafting procedures, regeneration, and tissue remodeling are developing therapies with great potential medical value. None of these therapeutic ...

    SBIR Phase I 2005 Department of Health and Human Services
  8. DEVELOPMENT OF AN HA2 DOMAIN BASED PERIODONTITIS VACCINE

    Amount: $113,397.00

    DESCRIPTION: ( Applicant's Abstract) Periodontal disease can be diagnosed in >50 percent of adults and may contribute to poor health through oral and systemic infection. The disease p ...

    SBIR Phase I 2001 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government